Editas Medicine Linkedin .hamburger .st0{fill:none;stroke:#FFFFFF;stroke-width:0.5;} WHAT IF WE COULD REPAIR BROKEN GENES? That is the question we ask ourselves at Editas Medicine. At Editas Medicine, we are pioneering the possible. Our mission and commitment is to harness the power and potential of CRISPR gene editing to develop a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable genomic medicines for many diseases. Animating slideshow of images Young woman holding her dog. Young man in hospital bed listening to a doctor. Geneticist in a lab working on genomic editing. EDITAS MEDICINE’S NEWSROOM NOV 12 Editas Medicine Presents Preclinical Data on Novel Engineered iPSC-derived NK Cells for the Treatment of Cancer at the Society for Immunotherapy of Cancer 36th Annual Meeting 1 2 3 WHAT WE’RE WORKING ON Our pipeline includes a broad range of experimental medicines. See what we’re working on. THE SCIENCE BEHIND IT ALL CRISPR (pronounced “crisper”) is an acronym for “Clustered, Regularly Interspaced, Short Palindromic Repeats,” and refers to a recently developed gene editing technology that can revise, remove, and replace DNA in a highly targeted manner. At Editas Medicine, we are using this technology to develop transformative and durable medicines for people living with serious diseases. THE PEOPLE WE SERVE We are motivated to deliver transformative medicines to the greatest number of patients around the world. Learn more about our commitment. ABOUT EDITAS MEDICINE Learn more about Editas Medicine, the work we do, and the team that makes everything possible. LIFE AT EDITAS MEDICINE Get to know our Inspiritas culture and see if any of our career openings could be right for you. Research and Pipeline CRISPR Gene Editing For Patients Who We Are Join Our Team Investors Terms of Use Privacy Policy Get in Touch Newsroom Editas Medicine Linkedin ©Copyright 2021 Editas Medicine